Annual revenue:
$450.71M+$119.30M(+36.00%)Summary
- As of today (May 10, 2025), BCRX annual revenue is $450.71 million, with the most recent change of +$119.30 million (+36.00%) on December 31, 2024.
- During the last 3 years, BCRX annual revenue has risen by +$293.54 million (+186.77%).
- BCRX annual revenue is now at all-time high.
Performance
BCRX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$145.53M+$14.00M(+10.64%)Summary
- As of today (May 10, 2025), BCRX quarterly revenue is $145.53 million, with the most recent change of +$14.00 million (+10.64%) on March 31, 2025.
- Over the past year, BCRX quarterly revenue has increased by +$52.77 million (+56.89%).
- BCRX quarterly revenue is now at all-time high.
Performance
BCRX Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$503.49M+$52.77M(+11.71%)Summary
- As of today (May 10, 2025), BCRX TTM revenue is $503.49 million, with the most recent change of +$52.77 million (+11.71%) on March 31, 2025.
- Over the past year, BCRX TTM revenue has increased by +$148.09 million (+41.67%).
- BCRX TTM revenue is now at all-time high.
Performance
BCRX TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
BCRX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.0% | +56.9% | +41.7% |
| 3 y3 years | +186.8% | +191.5% | +167.8% |
| 5 y5 years | +822.9% | +2917.5% | +954.0% |
BCRX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +186.8% | at high | +191.5% | at high | +167.8% |
| 5 y | 5-year | at high | +2430.4% | at high | +4969.1% | at high | +2726.7% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
BCRX Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $145.53M(+10.6%) | $503.49M(+11.7%) |
| Dec 2024 | $450.71M(+36.0%) | $131.53M(+12.3%) | $450.71M(+9.2%) |
| Sep 2024 | - | $117.08M(+7.1%) | $412.58M(+7.9%) |
| Jun 2024 | - | $109.33M(+17.9%) | $382.24M(+7.6%) |
| Mar 2024 | - | $92.76M(-0.7%) | $355.39M(+7.2%) |
| Dec 2023 | $331.41M(+22.4%) | $93.40M(+7.7%) | $331.41M(+4.4%) |
| Sep 2023 | - | $86.74M(+5.2%) | $317.56M(+3.6%) |
| Jun 2023 | - | $82.49M(+19.9%) | $306.64M(+5.9%) |
| Mar 2023 | - | $68.78M(-13.5%) | $289.68M(+7.0%) |
| Dec 2022 | $270.83M(+72.3%) | $79.55M(+4.9%) | $270.83M(+13.6%) |
| Sep 2022 | - | $75.83M(+15.7%) | $238.44M(+17.1%) |
| Jun 2022 | - | $65.53M(+31.3%) | $203.61M(+8.3%) |
| Mar 2022 | - | $49.92M(+5.9%) | $188.03M(+19.6%) |
| Dec 2021 | $157.17M(+782.4%) | $47.16M(+15.0%) | $157.17M(+37.8%) |
| Sep 2021 | - | $40.99M(-17.9%) | $114.03M(+44.1%) |
| Jun 2021 | - | $49.96M(+162.1%) | $79.14M(+146.9%) |
| Mar 2021 | - | $19.06M(+374.6%) | $32.05M(+79.9%) |
| Dec 2020 | $17.81M(-63.5%) | $4.02M(-34.2%) | $17.81M(-66.7%) |
| Sep 2020 | - | $6.10M(+112.5%) | $53.52M(+8.8%) |
| Jun 2020 | - | $2.87M(-40.5%) | $49.19M(+3.0%) |
| Mar 2020 | - | $4.82M(-87.9%) | $47.77M(-2.2%) |
| Dec 2019 | $48.84M(+136.5%) | $39.73M(+2138.0%) | $48.84M(+312.5%) |
| Sep 2019 | - | $1.77M(+22.6%) | $11.84M(+2.8%) |
| Jun 2019 | - | $1.45M(-75.4%) | $11.52M(-49.0%) |
| Mar 2019 | - | $5.89M(+115.7%) | $22.56M(+9.3%) |
| Dec 2018 | $20.65M(-18.0%) | $2.73M(+87.7%) | $20.65M(-5.3%) |
| Sep 2018 | - | $1.45M(-88.4%) | $21.81M(-25.1%) |
| Jun 2018 | - | $12.49M(+214.2%) | $29.12M(+47.6%) |
| Mar 2018 | - | $3.98M(+2.2%) | $19.73M(-21.7%) |
| Dec 2017 | $25.19M(-4.4%) | $3.89M(-55.6%) | $25.19M(-16.8%) |
| Sep 2017 | - | $8.76M(+182.7%) | $30.28M(+3.4%) |
| Jun 2017 | - | $3.10M(-67.2%) | $29.28M(-5.5%) |
| Mar 2017 | - | $9.44M(+5.1%) | $30.97M(+17.5%) |
| Dec 2016 | $26.35M(-45.4%) | $8.98M(+15.7%) | $26.35M(+19.9%) |
| Sep 2016 | - | $7.76M(+62.2%) | $21.97M(-12.8%) |
| Jun 2016 | - | $4.79M(-0.7%) | $25.20M(-45.5%) |
| Mar 2016 | - | $4.82M(+4.7%) | $46.25M(-4.2%) |
| Dec 2015 | $48.26M(+254.6%) | $4.60M(-58.1%) | $48.26M(-1.7%) |
| Sep 2015 | - | $10.99M(-57.5%) | $49.10M(+18.7%) |
| Jun 2015 | - | $25.84M(+278.6%) | $41.35M(+143.6%) |
| Mar 2015 | - | $6.83M(+25.3%) | $16.98M(+24.8%) |
| Dec 2014 | $13.61M(-21.5%) | $5.45M(+68.2%) | $13.61M(-27.3%) |
| Sep 2014 | - | $3.24M(+120.9%) | $18.73M(+4.7%) |
| Jun 2014 | - | $1.47M(-57.6%) | $17.88M(+3.7%) |
| Mar 2014 | - | $3.46M(-67.3%) | $17.23M(-0.6%) |
| Dec 2013 | $17.33M(-34.1%) | $10.57M(+342.3%) | $17.33M(+59.5%) |
| Sep 2013 | - | $2.39M(+191.0%) | $10.87M(-23.7%) |
| Jun 2013 | - | $821.00K(-76.9%) | $14.24M(-19.2%) |
| Mar 2013 | - | $3.55M(-13.3%) | $17.63M(-33.0%) |
| Dec 2012 | $26.29M(+33.9%) | $4.10M(-28.8%) | $26.29M(-4.1%) |
| Sep 2012 | - | $5.76M(+36.8%) | $27.42M(+1.9%) |
| Jun 2012 | - | $4.21M(-65.6%) | $26.90M(+1.8%) |
| Mar 2012 | - | $12.22M(+133.9%) | $26.43M(+34.5%) |
| Dec 2011 | $19.64M(-68.5%) | $5.22M(-0.5%) | $19.64M(-36.9%) |
| Sep 2011 | - | $5.25M(+40.5%) | $31.11M(-17.8%) |
| Jun 2011 | - | $3.73M(-31.3%) | $37.86M(-9.3%) |
| Mar 2011 | - | $5.43M(-67.4%) | $41.74M(-33.1%) |
| Dec 2010 | $62.38M(-16.4%) | $16.69M(+39.1%) | $62.38M(-38.0%) |
| Sep 2010 | - | $12.00M(+57.6%) | $100.58M(+1.5%) |
| Jun 2010 | - | $7.62M(-70.8%) | $99.13M(+2.9%) |
| Mar 2010 | - | $26.07M(-52.5%) | $96.30M(+29.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $74.59M(+31.9%) | $54.90M(+420.4%) | $74.59M(+38.3%) |
| Sep 2009 | - | $10.55M(+120.3%) | $53.93M(+3.2%) |
| Jun 2009 | - | $4.79M(+9.8%) | $52.28M(+4.2%) |
| Mar 2009 | - | $4.36M(-87.3%) | $50.15M(-11.3%) |
| Dec 2008 | $56.56M(-20.6%) | $34.24M(+285.0%) | $56.56M(+12.0%) |
| Sep 2008 | - | $8.89M(+234.5%) | $50.49M(-18.6%) |
| Jun 2008 | - | $2.66M(-75.3%) | $62.06M(-14.8%) |
| Mar 2008 | - | $10.77M(-61.8%) | $72.85M(+2.3%) |
| Dec 2007 | $71.24M(+1046.8%) | $28.17M(+37.7%) | $71.24M(+57.8%) |
| Sep 2007 | - | $20.46M(+52.2%) | $45.16M(+70.5%) |
| Jun 2007 | - | $13.44M(+46.8%) | $26.48M(+81.4%) |
| Mar 2007 | - | $9.16M(+337.8%) | $14.60M(+135.1%) |
| Dec 2006 | $6.21M(+3989.5%) | $2.09M(+16.9%) | $6.21M(+50.0%) |
| Sep 2006 | - | $1.79M(+14.9%) | $4.14M(+73.8%) |
| Jun 2006 | - | $1.56M(+102.1%) | $2.38M(+170.1%) |
| Mar 2006 | - | $771.00K(+3589.0%) | $881.90K(+480.6%) |
| Dec 2005 | $151.90K(-54.9%) | $20.90K(-34.7%) | $151.90K(-50.8%) |
| Sep 2005 | - | $32.00K(-44.8%) | $308.90K(-21.4%) |
| Jun 2005 | - | $58.00K(+41.5%) | $392.90K(+4.0%) |
| Mar 2005 | - | $41.00K(-77.0%) | $377.90K(+12.2%) |
| Dec 2004 | $336.90K(-48.4%) | $177.90K(+53.4%) | $336.90K(+1966.9%) |
| Sep 2004 | - | $116.00K(+169.8%) | $16.30K(-86.7%) |
| Jun 2004 | - | $43.00K(-130.1%) | $122.30K(-81.3%) |
| Dec 2003 | $653.30K(-94.1%) | -$142.70K(-164.3%) | $653.30K(-17.9%) |
| Sep 2003 | - | $222.00K(-16.5%) | $796.00K(-19.3%) |
| Jun 2003 | - | $266.00K(-13.6%) | $986.00K(+36.9%) |
| Mar 2003 | - | $308.00K(-25.2%) | $720.00K(-83.5%) |
| Sep 2002 | - | $412.00K(-23.6%) | $4.37M(-60.2%) |
| Mar 2002 | - | $539.00K(-84.2%) | $10.99M(-1.5%) |
| Dec 2001 | $11.16M(+236.5%) | $3.42M(+0.6%) | $11.16M(+30.6%) |
| Sep 2001 | - | $3.40M(-6.4%) | $8.54M(+44.7%) |
| Jun 2001 | - | $3.63M(+416.9%) | $5.90M(+70.9%) |
| Mar 2001 | - | $703.00K(-12.5%) | $3.45M(+4.2%) |
| Dec 2000 | $3.32M(+32.6%) | $803.60K(+5.3%) | $3.32M(+32.0%) |
| Sep 2000 | - | $763.00K(-35.6%) | $2.51M(+43.5%) |
| Jun 2000 | - | $1.19M(+110.1%) | $1.75M(-36.5%) |
| Mar 2000 | - | $564.00K(>+9900.0%) | $2.76M(-10.9%) |
| Dec 1999 | $2.50M(-60.9%) | - | - |
| Sep 1999 | - | $1000.00(-100.0%) | $3.09M(-66.0%) |
| Jun 1999 | - | $2.19M(+338.4%) | $9.09M(+29.9%) |
| Mar 1999 | - | $500.00K(+25.0%) | $7.00M(+6.1%) |
| Dec 1998 | $6.40M(+540.0%) | $400.00K(-93.3%) | $6.60M(+6.5%) |
| Sep 1998 | - | $6.00M(+5900.0%) | $6.20M(+1966.7%) |
| Jun 1998 | - | $100.00K(0.0%) | $300.00K(-75.0%) |
| Mar 1998 | - | $100.00K(0.0%) | $1.20M(+100.0%) |
| Dec 1997 | $1.00M(-37.5%) | - | - |
| Sep 1997 | - | $100.00K(-90.0%) | $600.00K(-25.0%) |
| Jun 1997 | - | $1.00M(+900.0%) | $800.00K(-46.7%) |
| Mar 1997 | - | $100.00K(-116.7%) | $1.50M(0.0%) |
| Dec 1996 | $1.60M(+700.0%) | -$600.00K(-300.0%) | $1.50M(-31.8%) |
| Sep 1996 | - | $300.00K(-82.4%) | $2.20M(+10.0%) |
| Jun 1996 | - | $1.70M(+1600.0%) | $2.00M(+400.0%) |
| Mar 1996 | - | $100.00K(0.0%) | $400.00K(-20.0%) |
| Dec 1995 | $200.00K(-71.4%) | $100.00K(0.0%) | $500.00K(-16.7%) |
| Sep 1995 | - | $100.00K(0.0%) | $600.00K(-14.3%) |
| Jun 1995 | - | $100.00K(-50.0%) | $700.00K(0.0%) |
| Mar 1995 | - | $200.00K(0.0%) | $700.00K(+16.7%) |
| Dec 1994 | $700.00K | $200.00K(0.0%) | $600.00K(+50.0%) |
| Sep 1994 | - | $200.00K(+100.0%) | $400.00K(+100.0%) |
| Jun 1994 | - | $100.00K(0.0%) | $200.00K(+100.0%) |
| Mar 1994 | - | $100.00K | $100.00K |
FAQ
- What is BioCryst Pharmaceuticals annual revenue?
- What is the all time high annual revenue for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual revenue year-on-year change?
- What is BioCryst Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly revenue year-on-year change?
- What is BioCryst Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals TTM revenue year-on-year change?
What is BioCryst Pharmaceuticals annual revenue?
The current annual revenue of BCRX is $450.71M
What is the all time high annual revenue for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual revenue is $450.71M
What is BioCryst Pharmaceuticals annual revenue year-on-year change?
Over the past year, BCRX annual revenue has changed by +$119.30M (+36.00%)
What is BioCryst Pharmaceuticals quarterly revenue?
The current quarterly revenue of BCRX is $145.53M
What is the all time high quarterly revenue for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly revenue is $145.53M
What is BioCryst Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, BCRX quarterly revenue has changed by +$52.77M (+56.89%)
What is BioCryst Pharmaceuticals TTM revenue?
The current TTM revenue of BCRX is $503.49M
What is the all time high TTM revenue for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high TTM revenue is $503.49M
What is BioCryst Pharmaceuticals TTM revenue year-on-year change?
Over the past year, BCRX TTM revenue has changed by +$148.09M (+41.67%)